CID 5951923 |
| Catalog No.GC14685 |
CID 5951923은 603nM의 IC50을 가진 KrÜppel-like factor 5(KLF5)의 강력한 억제제입니다. CID 5951923은 시험관 내에서 암세포의 증식을 억제할 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 749872-43-3
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 749872-43-3 | SDF | |
| Chemical Name | (S,E)-2-((1,1-dioxidotetrahydrothiophen-3-yl)(methyl)amino)-2-oxoethyl 3-(3-nitrophenyl)acrylate | ||
| Canonical SMILES | O=S1(C[C@H](CC1)N(C(COC(/C=C/C2=CC=CC([N+]([O-])=O)=C2)=O)=O)C)=O | ||
| Formula | C16H18N2O7S | M.Wt | 382.39 |
| Solubility | DMF: 20 mg/ml,DMF:PBS (pH 7.2) (1:5): 0.16 mg/ml,DMSO: 16 mg/ml | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6151 mL | 13.0757 mL | 26.1513 mL |
| 5 mM | 0.523 mL | 2.6151 mL | 5.2303 mL |
| 10 mM | 0.2615 mL | 1.3076 mL | 2.6151 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC39677 (Z)-JIB-04
- GC41573 Theaflavin 3,3'-digallate
- GN10599 Procyanidin B2
- GC32543 OPC-28326
- GC33317 HDAC6-IN-1
- GC38786 Glycyrrhetic acid 3-O-β-D-glucuronide
- GC44314 Naphthol AS-BI-Phosphate
- GC41448 AB-PINACA pentanoic acid metabolite
- GC18374 API-1
- GC37593 Satraplatin
- GC60889 Gut restricted-7
- GC30164 E3 ligase Ligand 4
- GC41035 (±)-JWH 073 N-(3-hydroxybutyl) metabolite
- GC37814 Tomatine
- GC31759 Indoprofen ((±)-Indoprofe)
- GN10399 Fuziline
- GC14915 Gemfibrozil
리뷰
Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *